A novel process for preparing anthranilic diamides and intermediates thereof”
Patent Information
- Application Number
- IN202011006455
- Authority / Receiving Office
- IN · IN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-02-14
- Publication Date
- 2026-07-13
- Estimated Expiration
- 2040-02-14
AI Technical Summary
Current processes for preparing anthranilic diamides are laborious and lack industrial efficiency and cost-effectiveness, necessitating a simpler and more environmentally friendly method.
A novel process involving the acylation of aniline to obtain a compound of Formula (VI), which is then converted into aminophenyl and subsequently used to synthesize anthranilic diamides of Formula (I), utilizing suitable solvents and reagents at controlled temperatures and pressures.
This process provides a cost-effective, industrially viable, and environmentally friendly method for preparing anthranilic diamides, overcoming the inefficiencies of prior art by simplifying the synthesis and reducing operational costs.
Abstract
Description
FIELD OF THE INVENTION:The present invention relates to a novel process for preparing anthranilic diamides involving the preparation of aminophenyl. The present invention also relates to a novel process for preparing aminophenyl.BACKGROUND OF THE INVENTION:Anthranilic diamides are a commercially important class of synthetic insecticides that bind to the ryanodine receptor with selective potency against insect versus mammalian forms of the receptor. The first commercialized anthranilic diamide of this class, chlorantraniliprole, has exceptional activity against lepidopteran pests. The second anthranilic diamide product of the same class, cyantraniliprole, has excellent cross-spectrum activity against a range of insect orders, including both lepidopteran and hemipteran pests. The PCT publications WO2003015518, WO2003015519, WO2004067528, WO2005077934 and WO20100069502 disclose the use of anthranilic diamides for controlling invertebrate pests such as arthropods.These anthranilic diamide compounds can be prepared from 3,5-substituted 2-amino-N-alkylbenzamidecompounds as intermediates. The PCT publication WO2013007603 discloses a process for preparation of2-amino-5-cyano-3-methyl(N-methyl)benzamide type compounds from 2-amino-5-cyano-3-methylbenzoic acid esters. Further, the synthesis of certain 3,5-substituted 2-amino-N-alkyl-benzamidecompounds and their utility as intermediates for preparing corresponding insecticidal anthranilic diamidecompounds has been disclosed in WO2004067528, WO2006068669, WO2006062978 andWO2012103436. Further, the process for the synthesis of cyano derivatives of anthranilic diamidecompounds or cyano functions containing intermediates thereof are disclosed in PCT publicationsWO2008010897, WO2008070158, WO2009085816, WO2009061991, WO2009006061 andWO2008082502.However, the processes described in the above mentioned literature are laborious, and there is still a needto find a simple, efficient and industrially economical process for the preparation of anthranilic diamidecompounds. Accordingly, the present invention provides a simple, environment-friendly and costeffectiveprocess for the preparation of anthranilic diamide compounds and intermediates thereof.OBJECT AND SUMMARY OF THE INVENTION:It is therefore an objective of the present invention to provide a novel and cost-effective process for thepreparation of anthranilic diamide compounds of Formula (I).Another objective of the present invention is to provide an industrially viable and convenient process forthe preparation of anthranilic diamides of Formula (I).Surprisingly, the present invention provides a solution to these objectives by providing a novel processthat allows the preparation of anthranilic diamides by overcoming at least one of the shortcomings of theprocesses described in the prior art.These objectives were achieved according to the present invention by providing a novel process forpreparing a compound of Formula (I),wherein,R1 is CH3, Br or Cl;R2 is F, Cl, Br, I, or CN;R3a and R3b are independently H, C1-C4 alkyl, C3-C6 cycloalkyl or C3-C6 cycloalkyl-C1-C4alkyl;R3c is independently H or C1-C4 alkyl;R4 is Cl, Br, CF3, OCF2H, OCH2CF3, C1-C4 haloalkyl or ;R5 is F, Cl or Br;R6 is H, F or Cl;Z is CR7 or N; andR7 is H, F, Cl or Br.The process of the present invention comprises the step of obtaining a compound of Formula (VI) whichis then converted into a corresponding aminophenyl of Formula (V);, and ,wherein, Y is CH3, O-C1-C6 alkyl, and NR3aR3b; R2 is H, F, Cl, Br, I, or CN; R1 and R3c are as definedherein before.The preparation of aminophenyl of Formula (V) and anthranilic diamides of Formula (I) therefrom isnovel and inventive.DETAILED DESCRIPTION OF THE INVENTION:GENERAL DEFINITIONSThe definitions provided herein for the terminologies used in the present disclosure are for illustrativepurpose only and in no manner limit the scope of the present invention disclosed in the present disclosure.As used herein, the terms "comprises", "comprising", "includes", "including", "has", "having","contains", "containing", "characterized by" or any other variation thereof, are intended to cover a nonexclusiveinclusion, subject to any limitation explicitly indicated. For example, a composition, mixture,process or method that comprises a list of elements is not necessarily limited to only those elements butmay include other elements not expressly listed or inherent to such composition, mixture, process ormethod.The transitional phrase "consisting of" excludes any element, step or ingredient not specified. If in theclaim, such would close the claim to the inclusion of materials other than those recited except forimpurities ordinarily associated therewith. When the phrase "consisting of" appears in a clause of thebody of a claim, rather than immediately following the preamble, it limits only the element set forth inthat clause; other elements are not excluded from the claim as a whole.The transitional phrase "consisting essentially of" is used to define a composition or method that includesmaterials, steps, features, components or elements, in addition to those literally disclosed, provided thatthese additional materials, steps, features, components or elements do not materially affect the basic andnovel characteristic(s) of the claimed invention. The term "consisting essentially of" occupies a middleground between "comprising" and "consisting of".Further, unless expressly stated to the contrary, "or" refers to an inclusive "or" and not to an exclusive"or". For example, a condition A "or" B is satisfied by any one of the following: A is true (or present) andB is false (or not present), A is false (or not present) and B is true (or present), and both A and B are true(or present).Also, the indefinite articles "a" and "an" preceding an element or component of the present invention areintended to be nonrestrictive regarding the number of instances (i.e. occurrences) of the element orcomponent. Therefore "a" or "an" should be read to include one or at least one, and the singular wordform of the element or component also includes the plural unless the number is obviously meant to besingular.Carbon-based radical refers to a monovalent molecular component comprising a carbon atom thatconnects the radical to the remainder of the chemical structure through a single bond. Carbon-basedradicals can optionally comprise saturated, unsaturated and aromatic groups, chains, rings and ringsystems, and heteroatoms. Although carbon-based radicals are not subject to any particular limit in size,in the context of the present invention they typically comprise 1 to 16 carbon atoms and o to 3heteroatoms. The carbon-based radicals are selected from C1-C6 alkyl, C1-C6 haloalkyl and phenyloptionally substituted with 1-3 substituents selected from C1-C3 alkyl, halogen and nitro.The meaning of various terms used in the description shall now be illustrated.The term "alkyl", used either alone or in compound words such as "alkylthio" or "haloalkyl" or -N(alkyl)or alkylcarbonylalkyl or alkylsuphonylamino includes straight-chain or branched C1 to C24 alkyl,preferably C1 to C15 alkyl, more preferably C1 to C10 alkyl, most preferably C1 to C6 alkyl. Representativeexamples of alkyl include methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl,1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl,1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and l-ethyl-2-methylpropyl or the different isomers. If thealkyl is at the end of a composite substituent, as, for example, in alkylcycloalkyl, the part of the compositesubstituent at the start, for example the cycloalkyl, may be mono- or polysubstituted identically ordifferently and independently by alkyl. The same also applies to composite substituents in which otherradicals, for example alkenyl, alkynyl, hydroxyl, halogen, carbonyl, carbonyloxy and the like, are at theend.The term "cycloalkyl" means alkyl closed to form a ring. Representative examples include but are notlimited to cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. This definition also applies to cycloalkylas a part of a composite substituent, for example cycloalkylalkyl etc., unless specifically definedelsewhere.The term "cycloalkylalkyl" means cycloalkyl substituent on alkyl, for example, cyclopropyl or cyclobutylor cyclopentyl are substituted on any carbon of C1-C6 alkyl.The present invention relates to a process for preparing anthranilic diamide compound of Formula (I),wherein,R1 is CH3, Br or Cl;R2 is F, Cl, Br, I, or CN;R3a and R3b are independently H, C1-C4 alkyl, C3-C6 cycloalkyl or C3-C6 cycloalkyl-C1-C4alkyl;R3c is independently H or C1-C4 alkyl;R4 is Cl, Br, CF3, OCF2H, OCH2CF3, C1-C4 haloalkyl or ;R5 is F, Cl or Br;R6 is H, F or Cl;Z is CR7 or N; andR7 is H, F, Cl or Br.The process of the present invention is described herein after.Initially, an aniline of Formula (VII), is acylated using a suitable acylating agent and optionally a suitablereagent to obtain a compound of Formula (VI),wherein, Y is CH3, O-C1-C6 alkyl, and NR3aR3b; R2 is H, F, Cl, Br, I, or CN R1, R2 and R3c are as definedherein before.The acylation of the aniline of Formula (VII) is carried out at a temperature ranging from 0 °C to 100 °Cin the presence of one or more suitable solvent / s.Non limiting examples of the suitable solvent useful for the purpose of acylating the aniline of Formula(VII) include aliphatic hydrocarbons such as hexane, heptane, octane, nonane, decane, dodecane and thelike; alicyclic hydrocarbons such as cycloalkanes: cyclopropane, cyclobutane, cyclopentane, cyclohexane,cycloheptane, cyclooctane, and the like; aromatic hydrocarbons such as toluene, xylene, mesitylene,benzene and the like; ethers such as diisopropyl ether, t-butyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, monoglyme, diglyme, methoxy-methane, methoxy-ethane ethoxy-ethane, dimethoxyethane,di-ethoxyethane and the like; halogenated hydrocarbons such as dichloromethane,chloroform, dichloroethane and like; polar aprotic solvents such as N,N-dimethylmethanamide, dimethylsulfoxide, N-methyl-2-pyrrolidone, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone,hexamethylphosphoramidem, 1,3-dimethyl-2-imidazolidinone and the like; and water.Non limiting examples of the suitable acylating agent useful for the purpose of acylating the aniline ofFormula (VII) include acyl halide, acetic acid, ethenone, and acetic anhydride.Non limiting examples of the suitable reagents useful for supporting the acylation of the aniline ofFormula (VII) is selected from the group consisting of alkylamines, dialkylamines, trialkylamines,pyridine, halogenated pyridines, 3-picoline, 4-picoline, quinoline, quinaldine, and alkylpyridines forexample 2,6-dimethylpyridine, 2-methyl-5-ethylpyridine, and 2,3-dimethylpyridine, ammonia,ammonium hydroxide, sodium hydroxide, potassium hydroxide, cesium hydroxide, lithium hydroxide,calcium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate,cesium carbonate, cesium bicarbonate, 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide, N,N'-Diisopropylcarbodiimide, O-(7-Azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluroniumhexafluorophosphate (HATU), O-(7-Azabenzotriazol-1-yl)- N,N,N',N'-tetramethyluroniumtetrafluoroborate (TATU), O-(6-Chlorobenzotriazol-1-yl)-N,N,N',N'-tetramethyluroniumhexafluorophosphate (HCTU), O-(N-Suc-cinimidyl)-1,1,3,3-tetramethyl-uronium tetrafluoroborate(TSTU), O-(5-Norbornene-2,3-dicarboximido)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TNTU),O-(1,2-Dihydro-2-oxo-1-pyridyl-N,N,N',N'-tetramethyluronium tetrafluoroborate (TPTU), 3-(Diethylphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT), (Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP), (Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP), (7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyAOP), Bromotripyrrolidinophosphoniumhexafluorophosphate (PyBrOP), O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluroniumhexafluorophosphate (HBTU) and O-(Benzotriazol-1-yl)- N,N,N',N'-tetramethyluroniumtetrafluoroborate (TBTU).The compound of Formula (VI), wherein Y is O-C1-C6 alkyl and NR3aR3b, is obtained by the processesreported in literature.For example, the compound of Formula (VI), wherein Y is O-C1-C6 alkyl, is obtained by reacting thecorresponding aniline of Formula (VII) with dialkyl carbonate as reported in WO2108210711 or withalkyl chloroformate as reported in WO2016168098. Another process is reported in the article titledSynthesis of methyl n-phenyl carbamate by amino-transesterification, Zhang, Guangxu et al,From Wuhan Ligong Daxue Xuebao, Volume 33(6), page no. 36-39; 2011.The compound of Formula (VI), wherein Y is NR3aR3b, is obtained by reacting the corresponding anilineof Formula (VII) with methyl isocyanate as reported in the article titled Intramolecular HydrogenBonding in Medicinal Chemistry, Kuhn, Bernd et al, From Journal of Medicinal Chemistry, Volume53(6), pages 2601-2611; 2010. Another process is reported Flash vacuum pyrolysis of 1,2,5-oxadiazole2-oxides and 1,2,3-triazole 1-oxides, Mitchell, William R. and Paton, R. Michael, From ARKIVOC(Gainesville, FL, United States), Volume (10), pages 34-54; 2010. The compound of Formula (VI),wherein Y is NR3aR3b, is obtained by reacting the corresponding aniline of Formula (VII) with carbamicchlorides.Subsequently, the compound of Formula (VI) is converted into aminophenyl of Formula (V) in thepresence of one or more suitable solvent / s and optionally using one or more suitable reagent;;wherein, R2 is H, F, Cl, Br, I, or CN; Y, R1 and R3c are as defined herein before.Non limiting examples of the suitable solvent useful for the purpose of converting the compound ofFormula (VI) into aminophenyl of Formula (V) include aliphatic hydrocarbons such as hexane, heptane,octane, nonane, decane, dodecane and the like; alicyclic hydrocarbons such as cycloalkanes:cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, and the like; aromatichydrocarbons such as toluene, xylene, mesitylene, benzene and the like; ethers such as diisopropyl ether,t-butyl methyl ether, tetrahydrofuran, 2-methyl tetrahydrofuran, dioxane, monoglyme, diglyme, methoxymethane,methoxy-ethane ethoxy-ethane, di-methoxyethane, di-ethoxyethane and the like; halogenatedhydrocarbons such as dichloromethane, chloroform, dichloroethane and like; polar aprotic solvents suchas N,N-dimethylmethanamide, dimethyl sulfoxide, N-methyl-2-pyrrolidone, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone, hexamethylphosphoramidem, 1,3-dimethyl-2-imidazolidinone and thelike; and water.Non limiting examples of the suitable reagent useful for the purpose of converting the compound ofFormula (VI) into aminophenyl of Formula (V) include aluminum bromide, aluminum chloride,aluminum isopropoxide, boron trichloride, boron trichloride methyl sulfide complex, boron trifluorideacetic acid complex, boron trifluroride acetonitrile complex, boron trifluoride dibutyl etherate, borontrifluoride diethyl etherate, boron trifluoride-methanol solution, boron trifluoride methyl etherate, borontrifluoride methyl sulfide complex, boron trifluoride phenol complex, boron trifluoride propanol complex,boron trifluoride tetrahydrofuran complex, dicyclohexylboron trifluoromethanesulfonate, tin (IV)chloride, titanium (IV) chloride, titanium (IV) chloride tetrahydrofuran, titanium (IV) isopropoxide, iron(III) bromide, iron (III) chloride, ytterbium (III) chloride, ytterbium (III) trifluoromethanesulfonate,ytterbium (III) triflate, ytterbium pentafluorobenzoate, phosphorous pentaxoide / peracetic acid,phosphorous pentafluoride, and methane sulfonic acid.In one embodiment, the conversion of the compound of Formula (VI) into aminophenyl of Formula (V) iscarried out at a temperature ranging from 20 °C to 200 °C, optionally, at a pressure ranging from 0.5kg / cm2 to 250 kg / cm2.In another embodiment, the conversion of the compound of Formula (VI) into aminophenyl of Formula(V) is carried out photo chemically,wherein, Y, R1, R2 and R3c are as defined herein before.In a particular embodiment, the conversion of the compound of Formula (VI) into aminophenyl ofFormula (V) is carried out photo chemically at a radiation of 10 nm to 400 nm and at a temperatureranging from 20 °C to 200 °C.In yet another embodiment, the conversion of the compound of Formula (VI) into aminophenyl ofFormula (V) is carried out in batch processes, semi-continuous processes, in continuous processes or inflow processes.In one of the embodiments, when R2 is H, the compound of Formula (VI) and or aminophenyl of Formula(V) are halogenated using suitable halogenating agents such as HX, NaX, KX, CuX2, MgX2, CsX, ZnX2,SOCl2, SO2Cl2, COCl2, X2, C(=O)(OCl3)2, t-BuOCl, NaOCl, Chloramine-T, N-halosuccinamides, POX3,PX3, PX5 or metal halides; wherein X is Cl, Br, I or F.In the subsequent step, aminophenyl of Formula (V), wherein Y is CH3 or O-C1-C6 alkyl, is convertedinto a compound of Formula (III),wherein, R1, R2, and R3c are as defined herein before.The conversion of aminophenyl of Formula (V) into the compound of Formula (III) is carried out at atemperature ranging from 20 °C to 200 °C in the presence of bromine or chlorine or iodine and aninorganic base which includes but is not limited to sodium hydroxide, potassium hydroxide, rubidiumhydroxide, cesium hydroxide, lithium hydroxide, calcium hydroxide, magnesium hydroxide or bariumhydroxide.The conversion of aminophenyl of Formula (V) into the compound of Formula (III) can also be carriedout using the oxidation processes known in the literature.The compound of Formula (III) can be converted into a compound of Formula (IV) by using any of themethods known in the prior art or as described in CN106146414A, WO2016131098, ACS Med. Chem.Lett., 2017, 8 (6), pp 678-681 and Chem. Commun., 2018, 54, 12766-12769,wherein, R1, R2, and R3c are as defined herein before.The compound of Formula (III) is then used in the synthesis of the compound of Formula (I). There areseveral ways for achieving the synthesis of compound of Formula (I) starting from compounds ofFormula (III), having been reported in WO2012103436, WO2008010897 and WO2006062978.In one of the ways, the compound of Formula (III) is converted into the compound of Formula (IV),followed by reacting the compound of formula (IV) with a compound of Formula (VIII) to obtain thecompound of Formula (I),wherein, R8 is hydroxy or halogen or C1-C6 alkoxy, and R1, R2, R3a, R3b, R3c, R4, R5, R6 and Z are asdefined herein before.In one embodiment, the compound of Formula (IV) may be isolated.In another embodiment, the compound of Formula (IV) may not be isolated.In another way, the compound of Formula (III) is reacted with a compound of Formula (VIII) to obtainthe compound of Formula (IIA) or Formula (IIB; when R3c represents hydrogen),Further, the compound of Formula (IIA) or Formula (IIB) is subsequently reacted with amine to obtainthe compound of Formula (I),wherein, R1, R2, R3a, R3b, R3c, R4, R5, R6, R8 and Z are as defined herein before.The compound of Formula (II) may optionally be converted into the corresponding acyl halide beforereacting with amine to obtain the compound of Formula (I).The compound of Formula (III) may optionally be converted into the corresponding acyl halide beforereacting acid of Formula (VIII) to obtain the compound of Formula (II).In one embodiment, the compound of Formula (II) or the corresponding acyl halide derived from themmay be isolated.In another embodiment, the compound of Formula (II) or the corresponding acyl halide may not beisolated.The present invention shall now be described in light of the following non-limiting examples.EXAMPLESScheme 1:Step-1Synthesis of N-(4-chloro-2-methylphenyl)acetamideTriethylamine (5.0 mL, 35.3 mmol) and acetyl chloride (3.0 mL, 42.4 mmol) were added sequentially to astirred solution of 4-chloro-2-methylaniline (5 g, 35.3 mmol) in dichloromethane (20 mL) at 0 °C. Theresulting reaction mixture was warmed to 25 °C and stirred further for 2 h. After completion of thereaction, the reaction mixture was diluted with dichloromethane (50 mL) and washed successively withwater (50 mL) and brine solution (50 mL). Dichloromethane layer was dried over anhydrous sodiumsulphate and concentrated under reduced pressure. The product precipitated upon addition of n-hexane(100 mL) was filtered and dried under reduced pressure to obtain N-(4-chloro-2-methylphenyl)acetamide(5.8 g, 31.9 mmol, 90 % yield).1HNMR (400 MHz, DMSO-d6) δ 9.30 (s, 1H), 7.44 (d, J = 8.6 Hz, 1H), 7.27 (d, J = 2.1 Hz, 1H), 7.18(dd, J = 8.6, 2.4 Hz, 1H), 2.18 (s, 3H), 2.04 (s, 3H). GCMS:
[183] .Step-2Synthesis of 1-(2-amino-5-chloro-3-methylphenyl)ethan-1-oneA solution of N-(4-chloro-2-methylphenyl)acetamide (1 g, 5.5 mmol) in acetonitrile (50 mL) wasdegassed by sonication (20 min) and purging nitrogen gas for 5 min. The solution was filled in a quartzflask and kept in a UV chamber for irradiation at 254 nm and 25 °C for 24 h. After 24 h, 20% of desiredproduct was formed along with 5% of 2-methyl-4-chloroaniline confirmed by LCMS. The reactionmixture was concentrated and was purified by CombiFlash system using 5-10% Ethyl acetate: Hexane toobtain 1-(2-amino-5-chloro-3-methylphenyl)ethan-1-one.1HNMR (400 MHz, CHLOROFORM-D) δ 7.73-7.54 (1H), 7.25-7.06 (1H), 6.21 (s, 2H), 2.71-2.58 (3H),2.22-2.06 (3H). LCMS: [184.04]M+1Step-3Synthesis of 2-amino-5-chloro-3-methylbenzoic acidTo a stirred solution of sodium hydroxide (54.5 mg, 1.4 mmol) in water (1 mL) and dioxane (0.5 mL),bromine (0.22 mL, 0.4 mmol) was added drop wise over 5 min at 0 °C. 1-(2-Amino-5-chloro-3-methylphenyl)ethan-1-one (25 mg, 0.14 mmol) in dioxane (0.5 mL) was added drop wise and stirred for 5h at 25 °C. After completion of the reaction, the reaction mixture was acidified (to pH 3) with 2 Mhydrochloric acid and extracted with ethyl acetate (2 x 15 mL). The combined ethyl acetate layers werewashed with brine (10 mL), dried over anhydrous sodium sulphate and concentrated under reducedpressure. The product was precipitated by the addition of n-hexane (20 mL). The resultant product wasfiltered and dried under reduced pressure to obtain 2-amino-5-chloro-3-methylbenzoic acid (15 mg, 0.11mmol, 59 % yield).1HNMR (400 MHz, DMSO-d6) δ 7.54 (d, J = 2.4 Hz, 1H), 7.22 (t, J = 1.8 Hz, 1H), 2.10 (s, 3H).
Claims
1. A process for preparing a compound of Formula (I), wherein, R1 is CH3, Br or Cl; R2 is H, F, Cl, Br, I, or CN; R3a and R3b are independently H, C1-C4 alkyl, C3-C6 cycloalkyl or C3-C6 cycloalkyl-C1-C4 alkyl; R3c is independently H or C1-C4 alkyl; R4 is Cl, Br, CF3, OCF2H, OCH2CF3, C1-C4 haloalkyl or ; R5 is F, Cl or Br; R6 is H, F or Cl; Z is CR7 or N; and R7 is H, F, Cl or Br; said process comprising the steps of: a) obtaining a compound of Formula (VI) by acylating a compound of Formula (VII) in a suitable solvent using suitable acylating agent; wherein, Y is CH3, O-C1-C6 alkyl and NR3aR3b; R1, R2 and R3c are as defined herein above; b) converting compound of Formula (VI) to compound of Formula (V) in at least one suitable solvent, optionally using at least one reagent; wherein, Y, R1, R2 and R3c are as defined herein above; c) converting compound of Formula (V) to compound of Formula (III) wherein Y, R1, R2 and R3c are as defined herein above; d) converting compound of Formula (III) to compound of Formula (IV) using amine; wherein, the compounds of Formula IV may or may not be isolated, R1, R2, R3a, R3b and R3c are as defined herein above, or; reacting compound of Formula (III) with compound of Formula (VIII) to obtain compound of Formula (IIA) or Formula (IIB); ; wherein, the compounds of Formula II may or may not be isolated, R8 is hydroxy or halogen or C1-C6 alkoxy, and R1, R2, R3c, R4, R5, R6 and Z are as defined herein above; e) reacting compound of Formula (IV) with compound of Formula (VIII) to obtain compound of formula (I); wherein, the compounds of Formula (IV) may or may not be isolated, R8 is hydroxy or halogen or C1-C6 alkoxy, and R1, R2, R3a, R3b, R3c, R4, R5, R6 and Z are as defined herein above, or; converting compound of Formula (II) to compound of Formula (I) using amine, wherein, the compounds of Formula (IIA) or Formula (IIB) may or may not be isolated, R1, R2, R3a, R3b, R3c, R4, R5, R6 and Z are as defined herein above.
2. The process as claimed in claim 1, wherein the suitable solvent in steps (a), (b), (c) and (d) is selected from the group consisting of aliphatic, alicyclic or aromatic hydrocarbons, halogenated hydrocarbons, ethers, nitriles, amides, alcohols or combinations thereof.
3. The process as claimed in claim 1, wherein the suitable solvent in steps (a), (b), (c) and (d) is selected from the group consisting of hexane, heptane, octane, nonane, decane, dodecane, cycloalkanes: cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, toluene, xylene, mesitylene, benzene, diisopropyl ether, t-butyl methyl ether, tetrahydrofuran, 2- methyl tetrahydrofuran, dioxane, monoglyme, diglyme, methoxy-methane, methoxy-ethane ethoxy-ethane, di-methoxyethane, di-ethoxyethane, dichloromethane, chloroform, dichloroethane, N,N-dimethylmethanamide, dimethyl sulfoxide, N-methyl-2-pyrrolidone, 1,3-dimethyl-3,4,5,6- tetrahydro-2(1H)-pyrimidinone, hexamethylphosphoramidem, 1,3-dimethyl-2-imidazolidinone or combinations thereof.
4. The process as claimed in claim 1, wherein, i. the step (a) is carried out at a temperature ranging from 0 °C to 100 °C; and ii. the suitable acylating agent in step (a) is selected from the group consisting of acyl halide, acetic acid, ethenone, and acetic anhydride;5. The process as claimed in claim 1, wherein step (a) is carried out in presence of suitable reagent selected from alkylamines, dialkylamines, trialkylamines, pyridine, 2,6-dimethylpyridine, 2- methyl-5-ethylpyridine, and 2,3-dimethylpyridine, ammonia, ammonium hydroxide, sodium hydroxide, potassium hydroxide, cesium hydroxide, lithium hydroxide, calcium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, cesium carbonate, cesium bicarbonate. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide, N,N'- Diisopropylcarbodiimide, and O-(7-Azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU).
6. The process as claimed in claim 1, wherein, i. the step (b) is carried out at a temperature ranging from 20 °C to 200 °C and a pressure ranging from 0.5 kg / cm2 to 250 kg / cm2; or ii. the step (b) is carried out photochemically at a radiation of 10 nm to 400 nm and at a temperature ranging from 20 °C to 200 °C; and7. The process as claimed in claim 1, wherein, step (b) is carried out in presence of suitable reagent selected from aluminum bromide, aluminum chloride, aluminum isopropoxide, boron trichloride, boron trichloride methyl sulfide complex, boron trifluoride acetic acid complex, boron trifluroride acetonitrile complex, boron trifluoride dibutyl etherate, boron trifluoride diethyl etherate, boron trifluoride-methanol solution, boron trifluoride methyl etherate, boron trifluoride methyl sulfide complex, boron trifluoride phenol complex, boron trifluoride propanol complex, boron trifluoride tetrahydrofuran complex, dicyclohexylboron trifluoromethanesulfonate, tin (IV) chloride, titanium (IV) chloride, titanium (IV) chloride tetrahydrofuran, titanium (IV) isopropoxide, iron (III) bromide, iron (III) chloride, ytterbium (III) chloride, ytterbium (III) trifluoromethanesulfonate, ytterbium (III) triflate, ytterbium pentafluorobenzoate, phosphorous pentaxoide / peracetic acid, phosphorous pentafluoride, and methane sulfonic acid.
8. The process as claimed in claim 1, wherein, i. the step (c) is carried out at a temperature ranging from 20 °C to 200 °C; and ii. the step (c) is carried out in the presence of bromine or chlorine or iodine and an inorganic base selected from sodium hydroxide, potassium hydroxide, rubidium hydroxide, cesium hydroxide, lithium hydroxide, calcium hydroxide, magnesium hydroxide or barium hydroxide.
9. The process as claimed in claim 1, wherein compound of Formula (VI) and (V), having R2 = H, are halogenated using suitable halogenating agents selected from HX, NaX, KX, CuX2, MgX2, CsX, ZnX2, SOCl2, SO2Cl2, COCl2, X2, C(=O)(OCl3)2, t-BuOCl, NaOCl, Chloramine-T, Nhalosuccinamides, POX3, PX3, PX5 or metal halides; wherein X is Cl, Br, I or F.
